Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis

John R. MacDonald, A Jay Gandolfi, I. Glenn Sipes

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

A variety of compounds were tested for their ability to inhibit the development of galactosamine-induced hepatic necrosis when administered 12 hr after the toxicant. Hepatic necrosis in male Sprague-Dawley rats was quantified by histopathologic examination 24 hr after a hepatotoxic dose of d(+)-galactosamine HCl (400 mg/kg, ip). Compounds found to have antinecrotic activity were not able to eliminate the accumulation of calcium associated with galactosamine-induced hepatic necrosis. Potent calcium chelators (EDTA and EGTA), compounds with aminoethanethiol-chelating structures (cysteamine and penicillamine), compounds that may be metabolized to aminoethanethiol structures in vivo (N-acetylcysteine, 2-aminoethylisothiourea, and cystamine), and a compound known to alter subcellular calcium sequestration (taurine) all inhibited galactosamine-induced hepatic necrosis. Compounds without antinecrotic effects (S-methylcysteamine, thioproline, dimercaptopropanesulfonic acid, and dimercaptosuccinic acid) do not possess structural or functional characteristics of the antinecrotic agents. It is suggested that chelation of free intercellular calcium or enhanced subcellular sequestration of calcium could explain the reduction of cytotoxic consequences of hepatic calcium accumulation observed in this model.

Original languageEnglish (US)
Pages (from-to)17-24
Number of pages8
JournalToxicology and Applied Pharmacology
Volume81
Issue number1
DOIs
StatePublished - 1985

Fingerprint

Galactosamine
Necrosis
Calcium
Liver
Chelation
Cystamine
Succimer
Cysteamine
Penicillamine
Egtazic Acid
Taurine
Acetylcysteine
Edetic Acid
Sprague Dawley Rats
Rats
Acids

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis. / MacDonald, John R.; Gandolfi, A Jay; Glenn Sipes, I.

In: Toxicology and Applied Pharmacology, Vol. 81, No. 1, 1985, p. 17-24.

Research output: Contribution to journalArticle

@article{f939d0db9c2e4551b7319e4f8cdff380,
title = "Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis",
abstract = "A variety of compounds were tested for their ability to inhibit the development of galactosamine-induced hepatic necrosis when administered 12 hr after the toxicant. Hepatic necrosis in male Sprague-Dawley rats was quantified by histopathologic examination 24 hr after a hepatotoxic dose of d(+)-galactosamine HCl (400 mg/kg, ip). Compounds found to have antinecrotic activity were not able to eliminate the accumulation of calcium associated with galactosamine-induced hepatic necrosis. Potent calcium chelators (EDTA and EGTA), compounds with aminoethanethiol-chelating structures (cysteamine and penicillamine), compounds that may be metabolized to aminoethanethiol structures in vivo (N-acetylcysteine, 2-aminoethylisothiourea, and cystamine), and a compound known to alter subcellular calcium sequestration (taurine) all inhibited galactosamine-induced hepatic necrosis. Compounds without antinecrotic effects (S-methylcysteamine, thioproline, dimercaptopropanesulfonic acid, and dimercaptosuccinic acid) do not possess structural or functional characteristics of the antinecrotic agents. It is suggested that chelation of free intercellular calcium or enhanced subcellular sequestration of calcium could explain the reduction of cytotoxic consequences of hepatic calcium accumulation observed in this model.",
author = "MacDonald, {John R.} and Gandolfi, {A Jay} and {Glenn Sipes}, I.",
year = "1985",
doi = "10.1016/0041-008X(85)90115-2",
language = "English (US)",
volume = "81",
pages = "17--24",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis

AU - MacDonald, John R.

AU - Gandolfi, A Jay

AU - Glenn Sipes, I.

PY - 1985

Y1 - 1985

N2 - A variety of compounds were tested for their ability to inhibit the development of galactosamine-induced hepatic necrosis when administered 12 hr after the toxicant. Hepatic necrosis in male Sprague-Dawley rats was quantified by histopathologic examination 24 hr after a hepatotoxic dose of d(+)-galactosamine HCl (400 mg/kg, ip). Compounds found to have antinecrotic activity were not able to eliminate the accumulation of calcium associated with galactosamine-induced hepatic necrosis. Potent calcium chelators (EDTA and EGTA), compounds with aminoethanethiol-chelating structures (cysteamine and penicillamine), compounds that may be metabolized to aminoethanethiol structures in vivo (N-acetylcysteine, 2-aminoethylisothiourea, and cystamine), and a compound known to alter subcellular calcium sequestration (taurine) all inhibited galactosamine-induced hepatic necrosis. Compounds without antinecrotic effects (S-methylcysteamine, thioproline, dimercaptopropanesulfonic acid, and dimercaptosuccinic acid) do not possess structural or functional characteristics of the antinecrotic agents. It is suggested that chelation of free intercellular calcium or enhanced subcellular sequestration of calcium could explain the reduction of cytotoxic consequences of hepatic calcium accumulation observed in this model.

AB - A variety of compounds were tested for their ability to inhibit the development of galactosamine-induced hepatic necrosis when administered 12 hr after the toxicant. Hepatic necrosis in male Sprague-Dawley rats was quantified by histopathologic examination 24 hr after a hepatotoxic dose of d(+)-galactosamine HCl (400 mg/kg, ip). Compounds found to have antinecrotic activity were not able to eliminate the accumulation of calcium associated with galactosamine-induced hepatic necrosis. Potent calcium chelators (EDTA and EGTA), compounds with aminoethanethiol-chelating structures (cysteamine and penicillamine), compounds that may be metabolized to aminoethanethiol structures in vivo (N-acetylcysteine, 2-aminoethylisothiourea, and cystamine), and a compound known to alter subcellular calcium sequestration (taurine) all inhibited galactosamine-induced hepatic necrosis. Compounds without antinecrotic effects (S-methylcysteamine, thioproline, dimercaptopropanesulfonic acid, and dimercaptosuccinic acid) do not possess structural or functional characteristics of the antinecrotic agents. It is suggested that chelation of free intercellular calcium or enhanced subcellular sequestration of calcium could explain the reduction of cytotoxic consequences of hepatic calcium accumulation observed in this model.

UR - http://www.scopus.com/inward/record.url?scp=0022382751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022382751&partnerID=8YFLogxK

U2 - 10.1016/0041-008X(85)90115-2

DO - 10.1016/0041-008X(85)90115-2

M3 - Article

C2 - 4049417

AN - SCOPUS:0022382751

VL - 81

SP - 17

EP - 24

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 1

ER -